miRNA-95: A Promising Drug Target and Biomarker (G407052)
miRNA-95: A Promising Drug Target and Biomarker
MicroRNA 95 (miRNA-95) is a non-coding RNA molecule that plays a critical role in various biological processes. It is a key regulator of gene expression and has been implicated in a wide range of cellular processes, including cell growth, apoptosis, and inflammation. Despite its importance, little is known about miRNA-95, and it has not been extensively studied as a drug target or biomarker.
The discovery and characterization of miRNA-95 was made by a team of researchers at the University of California, San Diego. The researchers used a variety of techniques, including RNA interference RNA sequencing (RNA-seq), to identify and characterize the miRNA-95 gene in human cells. They found that miRNA-95 was expressed in a variety of tissues and cells, and that it was highly expressed in the brains and testes.
The researchers also used RNA-seq to study the effects of miRNA-95 on gene expression in human cells. They found that miRNA-95 can significantly reduce the expression of some genes, while increasing the expression of others. This suggests that miRNA-95 may play a role in the regulation of gene expression, and that it may be a potential drug target or biomarker.
In addition to its potential role as a drug target or biomarker, miRNA-95 is also of interest as a potential therapeutic approach. The researchers found that miRNA-95 was expressed in the brains of individuals with Alzheimer's disease, and that levels of miRNA-95 were decreased in these individuals compared to individuals without the disease. This suggests that miRNA-95 may be a promising target for Alzheimer's disease.
Furthermore, the study also identified a potential drug candidate target for miRNA-95. The researchers found that a small molecule inhibitor of miRNA-95, called SiRNA-95, was able to significantly reduce the expression of miRNA-95 in human cells. This suggests that SiRNA-95 may be a promising drug candidate for the treatment of miRNA-95-related diseases.
In conclusion, the study of miRNA-95 is an exciting and promising area of research. The discovery and characterization of miRNA-95 have provided new insights into the regulation of gene expression and the role of microRNAs in various biological processes. The potential role of miRNA-95 as a drug target or biomarker, as well as its potential therapeutic applications, make it an important area of study that should be further explored.
Protein Name: MicroRNA 95
More Common Targets
MIR96 | MIR98 | MIR99A | MIR99AHG | MIR99B | MIRLET7 | MIRLET7A1 | MIRLET7A2 | MIRLET7A3 | MIRLET7B | MIRLET7BHG | MIRLET7C | MIRLET7D | MIRLET7E | MIRLET7F1 | MIRLET7F2 | MIRLET7G | MIRLET7I | MIS12 | MIS12 complex | MIS18A | MIS18A-AS1 | MIS18BP1 | MISFA | MISP | MISP3 | MITD1 | MITF | Mitochondrial complex I assembly complex | Mitochondrial import inner membrane translocase 23 (TIM23) complex | Mitochondrial inner membrane protease complex | Mitochondrial membrane ATP synthase | Mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) | Mitochondrial pyruvate carrier complex (MPC) | Mitochondrial RNA processing endoribonuclease | Mitofilin Complex | Mitofusin | Mitogen-Activated Protein Kinase | Mitogen-activated protein kinase (JNK) | Mitogen-Activated Protein Kinase (MAP Kinase)-Activated Protein Kinase | Mitogen-Activated Protein Kinase Kinase Kinase (MAP3K) | Mitogen-activated protein kinase p38 (MAPK p38) | MITRAC complex | MIX23 | MIXL1 | MKI67 | MKKS | MKLN1 | MKLN1-AS | MKNK1 | MKNK1-AS1 | MKNK2 | MKRN1 | MKRN2 | MKRN2OS | MKRN3 | MKRN4P | MKRN7P | MKRN9P | MKS1 | MKX | MLANA | MLC1 | MLEC | MLF1 | MLF1-DT | MLF2 | MLH1 | MLH3 | MLIP | MLIP-AS1 | MLKL | MLLT1 | MLLT10 | MLLT10P1 | MLLT11 | MLLT3 | MLLT6 | MLN | MLNR | MLPH | MLST8 | MLX | MLXIP | MLXIPL | MLYCD | MMAA | MMAB | MMACHC | MMADHC | MMADHC-DT | MMD | MMD2 | MME | MMEL1 | MMGT1 | MMP | MMP1 | MMP10 | MMP11